AD

Financial statements Medivena

Balance sheet of Medivena

Company age:
Age:
9 y. 2 m. 11 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of MEDIVENA

Year
2017
2019
2020
2021
2022
2023
2024
2025
Total assets 63 625,83 105 318,85 845 029,54 1 230 839,37 1 662 115,79 19 409 931,84 11 817 177,28 12 753 923,15
A. Fixed assets 0,00 0,00 19 300,00 16 500,00 13 700,00 477 173,17 9 878 566,51 10 358 877,21
B. Current assets 63 625,83 105 318,85 825 729,54 1 214 339,37 1 648 415,79 18 932 758,67 1 938 610,77 2 395 045,94
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 63 625,83 105 318,85 845 029,54 1 230 839,37 1 662 115,79 19 409 931,84 11 817 177,28 12 753 923,15
A. Equity -178 454,15 -179 884,67 515 054,11 -85 133,36 -1 278 465,32 11 273 922,91 11 264 397,24 12 068 264,88
B. Liabilities and provisions for liabilities 242 079,98 285 203,52 329 975,43 1 315 972,73 2 940 581,11 8 136 008,93 552 780,04 685 658,27
I. Long-term liabilities 0,00 0,00 0,00 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 242 079,98 285 203,52 329 975,43 1 315 972,73 1 760 581,11 3 453 934,81 552 780,04 519 377,45
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.
AD
AD